Abstract:Objective: Overt hypothyroidism confers an increased risk of non-alcoholic fatty liver disease (NAFLD). The liver plays a crucial role in the metabolism of cholesterol and triglycerides; thyroid hormones interact on hepatic lipid homeostasis. Thyroid function within the euthyroid range affects a number of health issues, including atherosclerosis development and biochemical markers of increased cardiovascular risk. However, the association of thyroid hormones with NAFLD in euthyroid subjects has not been unequivocally established. We therefore determined associations of thyroid hormone parameters with NAFLD among euthyroid subjects. Methods: The study was conducted in the Lifelines Cohort Study, a population-based cohort study of participants living in the North of the Netherlands. Only euthyroid subjects (thyroid-stimulating hormone (TSH) 0.5-4.0mU/L, free thyroxine (FT4) 11-19.5pmol/L and free triiodothyronine (FT3) 4.4-6.7pmol/L) older than 18years were included. Exclusion criteria were participants with excessive alcohol use, known hepatitis or cirrhosis, liver functions ≥ three times the upper limit, current cancer, non-white ancestry, previous or current use of thyroid medication and current use of lipid or glucose lowering medication. A priori defined liver biochemistry, thyroid function parameters and metabolic syndrome (MetS) were studied. NAFLD was defined by using the validated Fatty Liver Index (FLI); FLI≥60 was categorized as NAFLD. A P<0.01 was considered significant. Results: FLI≥60 was found in 4274 (21.1%) of 20,289 individuals (62.1% male, median age 46years) with increased prevalence of MetS (P<0.0001). In age- and sex-adjusted analysis FLI≥60 was independently associated with a higher FT3 (OR 1.34, 95% CI 1.29-1.39, per SD increment, P<0.0001) and a lower FT4 (OR 0.73, 95% CI 0.70-0.75, P<0.0001) but not by TSH. The strongest association was found for the FT3/FT4 ratio (OR 1.44, 95% CI 1.39-1.49, P<0.0001). These associations remained similar after additional adjustment for the presence of MetS. In subjects with enlarged waist circumference, TSH and FT4 were lower while FT3 was higher, resulting in an increased FT3/FT4 ratio (P<0.0001). Conclusions: Euthyroid subjects with suspected NAFLD are characterized by higher FT3, lower FT4 and higher FT3/FT4 ratio, probably consequent to central obesity.

Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study

Familial longevity is associated with decreased thyroid function

Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism

Human insulin/IGF-1 and familial longevity at middle age

Umbilical cord blood thyroid hormones are inversely related to telomere length and mitochondrial DNA copy number

Longevity, demographic characteristics, and socio-economic status are linked to triiodothyronine levels in the general population

Lipid metabolism in long-lived families: the Leiden Longevity Study

Familial longevity is marked by enhanced insulin sensitivity

Growth hormone secretion is diminished and tightly controlled in humans enriched for familial longevity

Lipoprotein particle profiles mark familial and sporadic human longevity

Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7R

Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study

Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers

Thyroid Function and Body Weight: A Community-Based Longitudinal Study

Longevity and Thyroid Dysfunctions in the Elderly

Relationship Between Serum Thyrotropin Levels and Metabolic Diseases in Older Adults

Lipidomics of familial longevity

A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function

Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study

Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling

Low levels of free triiodothyronine are associated with risk of cognitive impairment in older euthyroid adults